National Health InvestorsNYSE: NHI

Does National Health Investors (NHI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Although the financial results of National Health Investors (NHI) for the quarter ending in March 2024 provide an overview of the company's performance, it may be valuable to examine how certain key metrics stack up against analyst projections and figures from the same period last year.

National Health Investors, Inc. (NYSE:NHI) has shared information about the upcoming release of its first quarter results for the period ending March 31, 2024. The company intends to publish its earnings report after the market closes on Monday, May 6, 2024, and will conduct a conference call on Tuesday, May 7, 2024, at 11:00 a.m.

National Health Investors reported strong Q4-2023 results, beating revenue and funds from operations estimates. NHI's net operating income improved by 3.7%, but rising interest expenses offset most of the NOI increase. We highlight what we love and what keeps us out of this 6.6% yielder.

While the top- and bottom-line numbers for National Health Investors (NHI) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

National Health Investors (NHI) came out with quarterly funds from operations (FFO) of $1.09 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to FFO of $0.85 per share a year ago.

MURFREESBORO, TN / ACCESSWIRE / January 23, 2024 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the fourth quarter ended December 31, 2023. NHI plans to issue its earnings release after the market closes on Tuesday, February 20, 2024, and will host a conference call on the following day, Wednesday, February 21, 2024, at 11:00 a.m.

The senior housing sector appears to have hit a fundamental bottom, with reduced development activity and strong demand drivers. National Health Investors (NHI) is trading at a cheap valuation and has potential for recovery and growth. NHI's fundamentals are starting to recover, with occupancy and NOI margins improving, and there is room for further growth.

National Health Investors released its Q3-2023 results, showing improved funds from operations and funds available for distribution. We look at the journey NHI has made so far since 2020 in improving its portfolio. We examine the balance sheet and the valuation metrics and give you our verdict.